tetrandrine has been researched along with Acute Confusional Senile Dementia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cheung, KH; Ho, OK; Huang, AS; Iyaswamy, A; Kong, AH; Li, M; Liu, J; Song, J; Sreenivasmurthy, SG; Su, C; Tong, BC; Wu, AJ; Zhu, Z | 1 |
Fu, Y; Jiang, C; Li, Z; Liu, J; Ren, D; Wang, H; Wang, L; Yuan, J; Zhong, X | 1 |
Cui, DJ; Gan, HT; He, FQ; Huang, XL; Li, TK; Qiu, BY; Xie, Q; Zhang, XH | 1 |
Du, G; Li, Z; Ni, K | 1 |
4 other study(ies) available for tetrandrine and Acute Confusional Senile Dementia
Article | Year |
---|---|
Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies.
Topics: Alzheimer Disease; Animals; Calcium; Cognition; Disease Models, Animal; Mice; Mice, Transgenic; tau Proteins; Tauopathies | 2022 |
Tetrandrine ameliorated Alzheimer's disease through suppressing microglial inflammatory activation and neurotoxicity in the 5XFAD mouse.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzylisoquinolines; Disease Models, Animal; Mice; Mice, Transgenic; Microglia; Peptide Fragments | 2021 |
Tetrandrine attenuates spatial memory impairment and hippocampal neuroinflammation via inhibiting NF-κB activation in a rat model of Alzheimer's disease induced by amyloid-β(1-42).
Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Animals; Benzylisoquinolines; Calcium Channel Blockers; Disease Models, Animal; Drug Interactions; Electrophoretic Mobility Shift Assay; Encephalitis; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Hippocampus; Interleukin-1beta; Male; Maze Learning; Memory Disorders; Neurons; NF-kappa B; Peptide Fragments; Phosphorus Isotopes; Protein Binding; Rats; Rats, Sprague-Dawley; Time Factors; Tumor Necrosis Factor-alpha | 2011 |
[Simultaneous analysis of six effective components in the anti-Alzheimer's disease effective component group of Xiao-Xu-Ming Decoction].
Topics: Alzheimer Disease; Animals; Benzoates; Benzylisoquinolines; Bridged-Ring Compounds; Chromatography, High Pressure Liquid; Drugs, Chinese Herbal; Flavonoids; Glucosides; Monosaccharides; Monoterpenes; Xanthenes | 2007 |